Integration of diverse data sources for prediction of adverse drug events

Clinical Pharmacology and Therapeutics

Volumn 90, Issue 5, 2011, Pages 645-646

  Abernethy, D R ^a   Bai, J P F ^a   Burkhart, K ^a   Xie, H G ^a   Zhichkin, P ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOBENZAPRINE; SEROTONIN RECEPTOR;

BINDING AFFINITY; BIOINFORMATICS; DATA BASE; DIET SUPPLEMENTATION; DRUG EXPOSURE; DRUG MECHANISM; DRUG SAFETY; HUMAN; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW;

AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS, TRICYCLIC; HUMANS; SEROTONIN SYNDROME;

EID: 80055023058     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2011.171     Document Type: Review

References (10)

1. Mestres, J., Seifert, S.A. & Oprea, T.I. Linking pharmacology to cl inical reports: cy clobenzaprine and its po ssible association with se rotonin syndrome. Clin. Pharmacol. Ther. 90, 662-665 (2011).
2. Vidal, D., Garcia-Serna, R. & Mestres, J. Ligandbased approaches to in silico pharmacology. Methods Mol. Biol. 672, 489-502 (2011).
3. Hansch, C., Hoekman, D., Leo, A., Weiniger, D. & Selassie, C.D. Chembioinformatics: comparative QSAR at the interface of biology and chemistry. Chem. Rev. 102, 783-812 (2002). (Pubitemid 35377614)
4. Boran, A.D. & Iyengar, R. Systems approaches to polypharmacology and drug discovery. Curr. Opin. Drug Discov. Devel. 13, 297-309 (2010).
5. Abernethy, D.R., Woodcock, J. & Lesko, L.J. Pharmacological mechanism-based drug safety assessment and prediction. Clin. Pharmacol. Ther. 89, 793-797 (2011).
6. Lamb, J. et al. The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313, 1929-1935 (2006). (Pubitemid 44497995)
7. Yang, X., Huang, Y., Crowson, M., Li, J., Maitland, M.L. & Lussier, Y.A. Kinase inhibition-related adverse events predicted from in vitro kinome and clinical trial data. J. Biomed. Informatics 43, 376-384 (2010).
8. Keiser, M.J. & Hert, J. Off-target networks derived from ligand set similarity. Methods Mol. Biol. 575, 195-205 (2009).
9. Epstein, R.S. et al. Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness Study). J. Am. Coll. Cardiol. 55, 2804-2812 (2010).
10. Behrman, R.E., Benner, J.S., Brown, J.S., McClellan, M., Woodcock, J. & Platt, R. Developing the Sentinel System - a national resource for evidence development. N. Engl. J. Med. 364, 498-499 (2011).